Abstract
Cancer cells differ from the other cells by their ability to survive under conditions of enhanced oxidative stress. This property of cancer cells might also be an origin of resistance of tumors to drug treatment. Reactive oxygen species (ROS) overproduction (oxidative stress) might be responsible for both survival and death of cancer cells and the opposite effects of ROS signaling can depend on many reasons. In present work we consider several possible mechanisms of ROS effects on survival/death cancer cells: the different effects of two main reactive oxygen species paramagnetic free radical anion superoxide and diamagnetic molecule hydrogen peroxide, competition between protein kinases and phosphatases, and modification of ROS-depended enzyme/gene cascades. The oxidation of protein kinase B (Akt) by ROS might be of great importance for a shift of the survival to apoptotic signal in the enzymatic cascade. Dual effects of ROS overproduction on cancer cells appear to depend on the levels of oxidative stress: weak/ moderate oxidative stress enhances survival while severe oxidative stress induces cell death. The regulation of ROS overproduction by antioxidants and prooxidants is possibly an important promising way for cancer treatment.
Keywords: ROS signaling, cancer, survival, apoptosis, diabetes mellitus, N-acetylcysteine, deetherification, deprotonation, glycolysis, cytochrome-cardiolipi
Current Signal Transduction Therapy
Title:Enhanced Free Radical Status of Cancer Cells Success and Failure of Prooxidant/Antioxidant Treatment
Volume: 7 Issue: 3
Author(s): Igor Afanas'ev
Affiliation:
Keywords: ROS signaling, cancer, survival, apoptosis, diabetes mellitus, N-acetylcysteine, deetherification, deprotonation, glycolysis, cytochrome-cardiolipi
Abstract: Cancer cells differ from the other cells by their ability to survive under conditions of enhanced oxidative stress. This property of cancer cells might also be an origin of resistance of tumors to drug treatment. Reactive oxygen species (ROS) overproduction (oxidative stress) might be responsible for both survival and death of cancer cells and the opposite effects of ROS signaling can depend on many reasons. In present work we consider several possible mechanisms of ROS effects on survival/death cancer cells: the different effects of two main reactive oxygen species paramagnetic free radical anion superoxide and diamagnetic molecule hydrogen peroxide, competition between protein kinases and phosphatases, and modification of ROS-depended enzyme/gene cascades. The oxidation of protein kinase B (Akt) by ROS might be of great importance for a shift of the survival to apoptotic signal in the enzymatic cascade. Dual effects of ROS overproduction on cancer cells appear to depend on the levels of oxidative stress: weak/ moderate oxidative stress enhances survival while severe oxidative stress induces cell death. The regulation of ROS overproduction by antioxidants and prooxidants is possibly an important promising way for cancer treatment.
Export Options
About this article
Cite this article as:
Afanas'ev Igor, Enhanced Free Radical Status of Cancer Cells Success and Failure of Prooxidant/Antioxidant Treatment, Current Signal Transduction Therapy 2012; 7 (3) . https://dx.doi.org/10.2174/157436212802481637
DOI https://dx.doi.org/10.2174/157436212802481637 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Natural Sirtuin Modulators in Drug Discovery: A Review (2010 -2020)
Current Medicinal Chemistry Tumor-Targeting Peptides and Small Molecules as Anti-Cancer Agents to Overcome Drug Resistance
Current Medicinal Chemistry Cells Under Pressure – Treatment of Eukaryotic Cells with High Hydrostatic Pressure, from Physiologic Aspects to Pressure Induced Cell Death
Current Medicinal Chemistry Tumor Bone Diseases: Molecular Mechanisms and Opportunities for Novel Treatments
Current Medicinal Chemistry - Anti-Cancer Agents The Transcription Factor ETS-1: Its Role in Tumour Development and Strategies for its Inhibition
Mini-Reviews in Medicinal Chemistry Structural Basis and Therapeutic Implication of the Interaction of CCN Proteins with Glycoconjugates
Current Pharmaceutical Design Nanosponges Encapsulated Phytochemicals for Targeting Cancer: A Review
Current Drug Targets The Role of MDCT in Craniocervical Junction Pathologies: Pictorial Review
Current Medical Imaging Extracellular SH3 Domain Containing Proteins – Features of a New Protein Family
Current Protein & Peptide Science Cancer Metastasis as Disrupted Developmental Phenotype
Current Genomics Diquaternized Curarelike Myorelaxants: Structure and Biological Activity
Mini-Reviews in Medicinal Chemistry A Comprehensive Review of the Genus Pyrola Herbs in Traditional Uses, Phytochemistry and Pharmacological Activities
Current Topics in Medicinal Chemistry Ewing’s Sarcoma Cancer Stem Cell Targeted Therapy
Current Stem Cell Research & Therapy Antioxidant to Treat Osteoarthritis: Dream or Reality?
Current Drug Targets WISP1 (CCN4) Autoregulates its Expression and Nuclear Trafficking of β-Catenin during Oxidant Stress with Limited Effects upon Neuronal Autophagy
Current Neurovascular Research Snake Venom Phospholipases A2: A New Class of Antitumor Agents
Protein & Peptide Letters Current Concepts on the Management of Chordoma
Current Drug Therapy Alginate Bead-Encapsulated PEDF Induces Ectopic Bone Formation In Vivo in the Absence of Co-Administered Mesenchymal Stem Cells
Current Drug Targets Editorial [Hot topic: Bisphosphonates and Bone Diseases: Past, Present and Future (Guest Editor: Dominique HEYMANN)]
Current Pharmaceutical Design Targeting CSC-Related miRNAs for Cancer Therapy by Natural Agents
Current Drug Targets